Optimizing endpoints in early phase clinical trials of acute respiratory distress syndrome
Andrew J Boyle, Richard A Greendyk, Bram Rochwerg, Daniel F McAuley, Ewan C Goligher · 2026
Read Optimizing endpoints in early phase clinical trials of acute respiratory distress syndrome by Andrew J Boyle, Richard A Greendyk, Bram Rochwerg, Daniel F McAuley, Ewan C Goligher (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13424680.txt.
Description
Boyle and colleagues argue that early drug trials in severe lung failure need better yardsticks for success. The syndrome, called ARDS, fills the lungs with fluid and has no proven drug cure. Many past trials may have missed real gains by use of blunt end measures.
Death alone hides gains that fall short of saving life yet still help patients. The team backs a running scale that tracks each patient's state day by day. Such a scale can spot shifts in health path that one fixed date would miss. It can also weigh death and time on life support in one fair frame. Better yardsticks could help small early trials pick drugs worth large tests.
Catalog record
| CREATOR | Andrew J Boyle, Richard A Greendyk, Bram Rochwerg, Daniel F McAuley, Ewan C Goligher |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |